U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that to encourage use of his new invention, the shopping cart, market owner Sylvan Goldman hired fake shoppers to push the carts around his store in Oklahoma City? Seems his customers were reluctant to give up their hand-carried baskets.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Assignee: SmithKline Beecham p.l.c.


Location: BrentfordMiddlesex, GB
No. of patents: 31

NumberTitleIssue Date
7452906Pyridine derivatives as Raf kinase inhibitors
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy. ...
11/18/2008
7446106Pyridylfurans and pyrroles as Raf kinase inhibitors
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy. ...
11/04/2008
7432270N-aroyl cyclic amines
This invention relates to N-aroyl cyclic amine derivatives and their use as orexin antagonists wherein: Y represents a bond, oxygen, or a group (CH2)n, wherein n represents 1, 2 or 3;...
10/07/2008
7429579Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)
The invention provides compounds of formula (I): wherein: R2 and R3 independently represent various substituents; R1 and R4 independently represent H, F, Cl, Br, C1-2alkyl, C1alkoxy, OH, CN, or NO
09/30/2008
7423052Piperidine compounds for use as orexin receptor antagoinst
A invention relates to N aroyl cyclic amine derivatives and their use as pharmaceuticals, specifically as orexin receptor antagonists. ...
09/09/2008
7416853Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
The enzyme Lp-PLA2 in purified form, an isolated nucleic acid molecule encoding Lp-PLA2, the use of an inhibitor of the enzyme Lp-PLA2 in therapy and a method of screening compounds to identify those compounds. ...
08/26/2008
7405217N-aroyl piperazine derivatives as orexin receptor antagonists
This invention relates to N-aroyl cyclic amino derivatives and their use as pharmaceuticals. ...
07/29/2008
7405209Protease inhibitors
The present invention provides 4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such co...
07/29/2008
7399837Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided. ...
07/15/2008
7375105Pyridine substituted furan derivatives as Raf kinase inhibitors
Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy. Wherein X is O, CH2 CO, S or NH, or the moiety X—R
05/20/2008
7368574Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt., characterized in that it: (i) comprises water in the range of from 0.3 to 0.6 molar equivalents; and (ii) provides an infra red spect...
05/06/2008
7365077Piperazine bis-amide derivatives and their use as antagonists of the orexin receptor
Disclosed are piperazine bis-amide derivatives useful as antagonists of the orexin receptor and pharmaceutical compositions containing the same. ...
04/29/2008
7358366Thiazolidinedione derivative and its use as antidiabetic
A polymorphic form of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt (the “Polymorph”) characterised in that it provides: (i) an infra red spectrum containing peaks at 1752, 1546, 1154, 621, and 602 cm−1;...
04/15/2008
7351832Process for the preparation of thiazolidinedione derivatives
A process for preparing a compound of formula (I): or a tautomeric form thereof or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, wherein: A1 represents...
04/01/2008
7344869Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and hosts capable of improved clavulanic acid production
Novel bacterial genes, microorganisms and processes for improving the manufacture of 5R clavams, eg. clavulanic acid. ...
03/18/2008
72917405-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Mesylate salt
Disclosed are 5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione mesylate salts, or solvates thereof; processes for preparing such compounds, compositions comprising such compounds and the use of such compounds in medicine. ...
11/06/2007
7285557Pyrimidinones as melanin concentrating hormone receptor 1
A compound of formula (Ia) comprising a pharmaceutically acceptable salt or solvate thereof, formulations, processes of preparing, and methods of administering to mammals are provided ...
10/23/2007
7279152Use of polyphosphate as a tooth erosion inhibitors in acidic compositions
The use of polyphosphate in acidic oral compositions, especially acid beverages with a pH between 2.2 and 5.5, to alleviate or prevent the tooth damage associated with the consumption of acid. The invention may be practiced using polyphosphate alone or in combinatio...
10/09/2007
7276229Oral compositions comprising a viscosity modifier for reduction of tooth erosion
The use of viscosity modifying polymer materials, commonly used as stabilisers, thickeners and emulsifiers, as tooth erosion inhibitors in acidic compositions for oral administration, especially in acidic beverages such as fruit drinks and oral healthcare products s...
10/02/2007
7241579Method of screening for GPR40 ligands
Methods of screening for ligands of the GPR40 receptor are provided, including methods utilizing fatty acid GPR40 ligands. ...
07/10/2007
7235658Imidazol derivatives as Raf kinase inhibitors
Compounds of formula (I): wherein X is O, CH2, S or NH, or the moiety X—R1 is hydrogen; V is CH or N; R1 is ...
06/26/2007
72301095-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
A hydrate of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, characterized in that it: (i) comprises water in the range of from 0.4 to 2.5% w/w; and (ii) provides an infra red spectrum containing peaks at 1749, 1703, 1645...
06/12/2007
7220777Lactam derivatives as antagonists for human 11cby receptors
The invention provides compounds of formula (I) a salt, or solvate thereof. ...
05/22/2007
7217535Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
The enzyme Lp-PLA2 in purified form, an isolated nucleic acid molecule encoding Lp-PLA2, the use of an inhibitor of the enzyme Lp-PLA2 in therapy and a method of screening compounds to identify those compounds. ...
05/15/2007
7214389Process
A wet granulation process in which a pharmaceutical substance is granulated using a granulating fluid which is a halogenated hydrocarbon which has a normal boiling point below ambient temperature, for example 1,1,1,2-tetraflouroethane, under a pressure sufficient to...
05/08/2007
7199137Imidazole derivatives as Raf kinase inhibitors
Novel compounds (I) and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy wherein Ar is a group of formula a) or b). ...
04/03/2007
6696457Morphinoid compounds
Heterocycle condensed morphinoid derivatives of formula (I) have therapeutic utility as analgesics, in collagen disease, as anti-allergic and anti-inflammatory agents, brain cell protectants, in gastritis, diarrhoea, cardiovascular and respiratory disease...
02/24/2004
6235753Inhibitors of the production of S-CD23 and the secretion of TNF
Inhibitors of the Production of s-CD23 and the secretion of TNF are provided....
05/22/2001
6046210Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
This invention relates to compounds of formula (I): ##STR1## which are useful as modulators of D3 receptors, in particular in the treatment of psychoses....
04/04/2000
6047109Methods and systems for re-evaluating assembly consensus sequences
A computational method maximizing open reading frame length in an assembly consensus sequence is provided. Systems employing the method are also provided....
04/04/2000
5962501Enantiomer of carbazole derivative as 5-HT1-like agonists
A (+) or (-) enantiomer of a compound of formula (I) wherein R4 is methyl or ethyl, or a salt, solvate, or hydtrate thereof, processes for preparing said compounds and pharmaceutical compostions containing them. Compounds of formula (+) are 5-H...
10/05/1999
 
Sign InRegister
Username  
Password   
forgot password?